Internal FDA study reveals deficiencies in 510(k) process and highlights areas for potential improvement.
New FDA study: Insufficient 510(k) submissions causing bulk of 510(k) review delays - MassDevice: "A new analysis of 510(k) premarket review timeframes by the US Food and Drug Administration cites response times from companies to additional information requests as the key causes of review delays."
